The group acknowledges limited growth in South Africa’s price-regulated pharma market but believes Natco’s backing will ...

Hyderabad: Dr. Reddy’s Laboratories Ltd has announced an investment of Rs 565.4 crore in its step-down wholly owned ...

A recent history of NIFTY MIDCAP performance shows a volatile performance. It had alternating gains and losses in the past 4 ...

The Nifty Pharma index ended Friday on a positive note, advancing 0.54%. Top gainers included Cipla Ltd and Torrent Pharmaceuticals Ltd, while Natco Pharma Ltd led the losses.

Natco Pharma’s R4-billion proposal to take a stake of almost 36% in Adcock Ingram was a vote of confidence in the JSE-listed ...

The U.S. FDA had inspected the API facility, in Mekaguda here, from June 9-13 and issued Form 483 with one observation. The regulator had classified it as “voluntary action indicated” (VAI), the ...

On Thursday, 1644 stocks advanced, 2409 declined and 168 remained unchanged on Bombay Stock Exchange with advance decline ...

Adcock Ingram surged the most on record after India’s Natco Pharma said it will acquire a stake in the South African drugmaker for about $232 million (R4 billion).

Natco Pharma informed that the U.S. Food and Drug Administration (US FDA) has issued an EIR for its active pharmaceutical ingredient (API) division located in Mekaguda, Hyderabad, Telangana.

Stock market today opened with mixed signals as investors reacted to global cues and Q1 earnings from major companies. The ...

Indian pharmaceutical company Natco Pharma Ltd has decided to acquire a 35.75% stake in South Africa’s Adcock Ingram ...

Natco’s proposed all-cash deal to acquire nearly 36% of AIHL from minority shareholders is aimed at expanding its presence in ...